Enanta Pharmaceuticals Inc (ENTA)
Net Income Growth
-6.83%
Quarterly · Period ending:
ENTA Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported-6.83%period ending
Latest reported-6.83%period ending
ENTA Quarterly Net Income YoY % (-1.58% → -6.83%)
Year-over-year change
High-resolution chart · PNG
ENTA net income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Income Growth |
|---|---|
| -6.8255% | |
| 42.1878% | |
| 46.4424% | |
| 35.1213% | |
| 19.4324% | |
| 27.3229% | |
| 33.2775% | |
| -2.5474% | |
| 41.9992% | |
| 17.2633% | |
| -15.2522% | |
| -6.676% | |
| -23.2334% | |
| -12.1041% | |
| 3.749% | |
| -7.11% | |
| -31.9514% | |
| -52.3792% | |
| -261.6114% | |
| 16.1617% | |
| -68.4122% | |
| -267.1107% | |
| -161.9505% | |
| -419.2362% | |
| -302.743% | |
| -244.8733% | |
| -48.318% | |
| -66.4807% | |
| -65.3194% | |
| -66.9853% | |
| 122.4493% | |
| -24.8932% | |
| 340.7785% | |
| 332.845% | |
| 334.7992% | |
| 2,125.9711% | |
| -683.0855% | |
| -227.7812% | |
| -119.0156% | |
| -131.0048% | |
| -144.4996% | |
| -105.7211% | |
| -37.6586% | |
| 215.2717% | |
| -95.1691% | |
| 652.6235% | |
| 882.2905% | |
| -13.4819% | |
| 1,309.594% | |
| -38.7837% | |
| -124.4569% | |
| -9.6496% | |
| -18.1948% | |
| -111.6751% | |
| 795.0617% | |
| -1.5793% |